Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

Phendimetrazine Tartrate

CompanyA-S Medication Solutions (DUNS: 830016429)

Effective Date

February 4, 2023

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Phendimetrazine(35 mg in 1 1)

Manufacturing Establishments (1)

A-S Medication Solutions

Labeler

A-S Medication Solutions

DUNS Number

830016429

Products (1)

Phendimetrazine Tartrate

NDC Product Code

50090-2235

Application Number

ANDA091042

Marketing Category

ANDA (C73584)

Route of Administration

ORAL

Effective Date

December 11, 2019

Ingredients

SILICON DIOXIDEInactive

Code: ETJ7Z6XBU4Class: IACT

FD&C BLUE NO. 1Inactive

Code: H3R47K3TBDClass: IACT

LACTOSE MONOHYDRATEInactive

Code: EWQ57Q8I5XClass: IACT

STEARIC ACIDInactive

Code: 4ELV7Z65APClass: IACT

MICROCRYSTALLINE CELLULOSEInactive

Code: OP1R32D61UClass: IACT

SODIUM STARCH GLYCOLATE TYPE A POTATOInactive

Code: 5856J3G2A2Class: IACT

PhendimetrazineActive

Code: 6985IP0T80Class: ACTIBQuantity: 35 mg in 1 1

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy